Skip to content

INAVIUS

Active
Private limited companyfounded 2011active for 15 yearsEikestraat 111, 3080 Tervuren, BelgiumKBO/BCE: BE 0834.644.814
Summary

INAVIUS has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €196,876 and a net result of €9,714. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 52% of 20,397 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
2 sites
Size
€300,336total assets 2025
Equity
€196,876
Profit
€9,714
Turnover not published (micro format)
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 4 days early1 of 5 deeds read
Why 93lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.87, cash €95,020Size: total assets €300,336Equity €196,876 (65.6% of total assets)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 43% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 91+2
equity 65.6% of total assets
Liquidity 74-10
short-term debt 34.4% · cash 31.6%
Profitability 73-27
return on assets 3.2%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,071 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025highest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €18,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.87, compared with 2.08 in 2024, above the usual 1.5; short-term debt: 34.4% and cash: 31.6% of total assets), and 34.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 53% on solvency, 55% on liquidity, 16% on profitability and 46% on growth.

The bankruptcy probability was computed on 16-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.87, cash €95,020
NBB · annual accounts
lowers risk · Size: total assets €300,336
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €196,876 (65.6% of total assets)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
19202122232425
2019 to 2025 · latest year €196,876
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 27-01-2026, 4 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
4 days early
2024
13 days late
2023
21 days early
2022
7 days early
2021
10 days early
2020
24 days early
2019
1 day early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 8 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 24 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end16-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Capital & shares · Purpose ·…Declaration · Purpose change ·…

Financials · financial year 2025, micro format

Equity
€196,876▲ 5.2%
2024 · €187,162
Total assets
€300,336▲ 2.9%
2024 · €291,880
Net result
€9,714▼ 89.1%
2024 · €88,988
Working capital
€90,521▼ 20.2%
2024 · €113,368
Trend over the years

2021 to 2025, 5 financial years 2019 to 2025, 7 financial years

The operating result falls in 2025; 2025 is 86% below 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€17,890 2025 Net result€9,714 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2019202020212022202320242025
Operating result€2,509-€8,834▲ 252%€71,973▲ 715%-€12,238€54,794€127,886▲ 133%€17,890▼ 86.0%
Net result€1,230-€5,490below the sector's middle half▲ 346%€49,340within the sector's middle half▲ 799%-€12,752below the sector's middle half€38,881within the sector's middle half€88,988within the sector's middle half▲ 129%€9,714below the sector's middle half▼ 89.1%
Equity€440,400-€445,889above the sector's middle half▲ 1.2%€156,745within the sector's middle half▼ 64.8%€97,641within the sector's middle half▼ 37.7%€136,522within the sector's middle half▲ 39.8%€187,162within the sector's middle half▲ 37.1%€196,876within the sector's middle half▲ 5.2%
Total assets€480,095-€485,423within the sector's middle half▲ 1.1%€520,537within the sector's middle half▲ 7.2%€479,556within the sector's middle half▼ 7.9%€197,262within the sector's middle half▼ 58.9%€291,880within the sector's middle half▲ 48.0%€300,336within the sector's middle half▲ 2.9%
Debt€39,695-€39,534▼ 0.4%€363,792▲ 820%€381,915▲ 5.0%€60,740▼ 84.1%€104,718▲ 72.4%€103,460▼ 1.2%
Working capital€413,465-€419,793above the sector's middle half▲ 1.5%€137,588within the sector's middle half▼ 67.2%€90,571within the sector's middle half▼ 34.2%€116,974within the sector's middle half▲ 29.2%€113,368within the sector's middle half▼ 3.1%€90,521within the sector's middle half▼ 20.2%
Solvency91.7%-91.9%above the sector's middle half▲ 0.1pp30.1%below the sector's middle half▼ 61.7pp20.4%below the sector's middle half▼ 9.8pp69.2%within the sector's middle half▲ 48.8pp64.1%within the sector's middle half▼ 5.1pp65.6%within the sector's middle half▲ 1.4pp
Current ratio16.76-12.61above the sector's middle half▼ 4.151.38below the sector's middle half▼ 11.231.24below the sector's middle half▼ 0.142.93within the sector's middle half▲ 1.692.08within the sector's middle half▼ 0.841.87within the sector's middle half▼ 0.21
Return on assets (ROA)0.3%-1.1%below the sector's middle half▲ 0.9pp9.5%within the sector's middle half▲ 8.3pp-2.7%below the sector's middle half▼ 12.1pp19.7%within the sector's middle half▲ 22.4pp30.5%within the sector's middle half▲ 10.8pp3.2%below the sector's middle half▼ 27.3pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €300,336
Fixed assets €106,355 ▲ 44.1%
Current assets €193,981 ▼ 11.1%
Equity and liabilities €300,336
Equity €196,876 ▲ 5.2%
Debt €103,460 ▼ 1.2%
Debt's share of the balance-sheet total falls from 35.9% to 34.4%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€37,475▼
2024 · €137,109
Cash flow
€29,300▼
2024 · €98,211
Debt to equity
0.53▼
2024 · 0.56
ROE
4.9%▼
2024 · 47.5%
Interest coverage
9.63▼
2024 · 49.13
Debt ≤ 1 year
€103,460▼
2024 · €104,718
Income taxes
€4,762▼
2024 · €36,512
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 10,905 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 95.1% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet
0.7% went bankrupt
4.0% stopped otherwise
95.1% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,474 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 10,905 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines
Balance sheet Code20242025
Assets
Total assets20/58€291,880€300,336▲
Fixed assets21/28€73,794€106,355▲
Tangible fixed assets22/27€71,608€106,355▲
Plant, machinery and equipment23€695€315▼
Furniture and vehicles24€11,086€15,240▲
Other tangible fixed assets26€59,827€90,800▲
Financial fixed assets28€2,185€0▼
Current assets29/58€218,086€193,981▼
Amounts receivable within one year40/41€3,477€60,832▲
Trade receivables40€3,477€34,381▲
Other amounts receivable41€0€26,451▲
Cash at bank and in hand54/58€142,324€95,020▼
Deferred charges and accrued income490/1€72,286€38,129▼
Equity and liabilities
Total equity and liabilities10/49€291,880€300,336▲
Equity10/15€187,162€196,876▲
Contributions10/11€12,400€12,400=
Reserves13€174,762€184,476▲
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€174,762€184,476▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€104,718€103,460▼
Amounts payable within one year42/48€104,718€103,460▼
Trade debts44€3,330€39,445▲
Suppliers440/4€3,330€39,445▲
Taxes, remuneration and social security45€28,193€7,605▼
Taxes450/3€22,470€7,605▼
Remuneration and social security454/9€5,723€0▼
Other amounts payable47/48€73,195€56,410▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9,223€19,586▲
Other operating charges640/8€1,865€2,429▲
Gross operating margin9900€138,974€39,904▼
Operating profit (loss)9901€127,886€17,890▼
Financial income75/76B€404€478▲
Recurring financial income75€404€478▲
Financial charges65/66B€2,791€3,892▲
Recurring financial charges65€2,791€3,892▲
Profit (loss) for the period before taxes9903€125,500€14,476▼
Income taxes67/77€36,512€4,762▼
Profit (loss) for the period9904€88,988€9,714▼
Profit (loss) for the period to be appropriated9905€88,988€9,714▼
Appropriation of the result
Profit (loss) to be appropriated9906€88,988€9,714▼
Profit (loss) brought forward from the previous period14P€0-
Transfer from equity791/2€38,348€0▼
Transfer to equity691/2€88,988€9,714▼
To other reserves6921€88,988€9,714▼
Profit to be distributed694/7€38,348€0▼
Return on contributions (dividend)694€38,348€0▼

The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2019202020212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€18,442€13,035€12,517€12,087€4,025€9,223€19,586▲ 112%
Other operating charges640/8---€1,064€1,131€1,865€2,429▲ 30.3%
Gross operating margin9900€22,002€22,821€85,506€912€59,950€138,974€39,904▼ 71.3%
Operating profit (loss)9901€2,509€8,834€71,973-€12,238€54,794€127,886€17,890▼ 86.0%
Financial income75/76B---€0€149€404€478▲ 18.2%
Recurring financial income75€1,004€793€2€0€149€404€478▲ 18.2%
Financial charges65/66B---€261€4,165€2,791€3,892▲ 39.5%
Recurring financial charges65€471€627€1,634€261€4,165€2,791€3,892▲ 39.5%
Profit (loss) for the period before taxes9903€3,042€9,000€70,341-€12,499€50,778€125,500€14,476▼ 88.5%
Income taxes67/77€1,812€3,510€21,001€253€11,897€36,512€4,762▼ 87.0%
Profit (loss) for the period9904€1,230€5,490€49,340-€12,752€38,881€88,988€9,714▼ 89.1%
Profit (loss) for the period to be appropriated9905€1,230€5,490€49,340-€12,752€38,881€88,988€9,714▼ 89.1%
Line2019202020212022202320242025Change
Assets
Total assets20/58€480,095€485,423€520,537€479,556€197,262€291,880€300,336▲ 2.9%
Fixed assets21/28€40,401€29,475€19,157€7,070€19,548€73,794€106,355▲ 44.1%
Intangible fixed assets21€4,931€3,501€2,072€642€0---
Tangible fixed assets22/27€33,186€23,689€14,900€4,243€17,363€71,608€106,355▲ 48.5%
Plant, machinery and equipment23---€1,455€1,075€695€315▼ 54.6%
Furniture and vehicles24---€2,788€2,244€11,086€15,240▲ 37.5%
Other tangible fixed assets26----€14,044€59,827€90,800▲ 51.8%
Financial fixed assets28€2,285€2,285€2,185€2,185€2,185€2,185€0▼ 100%
Current assets29/58€439,693€455,948€501,380€472,486€177,714€218,086€193,981▼ 11.1%
Amounts receivable within one year40/41€11,281-€2,441€17,635€6,893€3,477€60,832▲ 1,650%
Trade receivables40-----€3,477€34,381▲ 889%
Other amounts receivable41---€17,635€6,893€0€26,451-
Cash at bank and in hand54/58€327,096€370,097€435,839€405,186€122,208€142,324€95,020▼ 33.2%
Deferred charges and accrued income490/1---€49,665€48,613€72,286€38,129▼ 47.3%
Equity and liabilities
Total equity and liabilities10/49€480,095€485,423€520,537€479,556€197,262€291,880€300,336▲ 2.9%
Equity10/15€440,400€445,889€156,745€97,641€136,522€187,162€196,876▲ 5.2%
Contributions10/11€12,400--€12,400€12,400€12,400€12,400=
Reserves13€428,000€433,489€144,345€95,456€124,122€174,762€184,476▲ 5.6%
Non-distributable reserves130/1---€1,860€1,860€0--
Reserves not available under the articles1311---€1,860€1,860€0--
Distributable reserves133---€93,596€122,262€174,762€184,476▲ 5.6%
Profit (loss) carried forward14----€10,215€0€0€0-
Amounts payable17/49€39,695€39,534€363,792€381,915€60,740€104,718€103,460▼ 1.2%
Amounts payable after more than one year17€13,467€3,379€0-----
Amounts payable within one year42/48€26,229€36,155€363,792€381,915€60,740€104,718€103,460▼ 1.2%
Current portion of amounts payable after more than one year42---€0----
Trade debts44€530€468€432€243€543€3,330€39,445▲ 1,085%
Suppliers440/4---€243€543€3,330€39,445▲ 1,085%
Taxes, remuneration and social security45---€11,782€3,590€28,193€7,605▼ 73.0%
Taxes450/3---€8,518€3,590€22,470€7,605▼ 66.2%
Remuneration and social security454/9---€3,265€0€5,723€0▼ 100%
Other amounts payable47/48---€369,890€56,607€73,195€56,410▼ 22.9%
Line2019202020212022202320242025Change
Profit (loss) for the period9904€1,230€5,490€49,340-€12,752€38,881€88,988€9,714▼ 89.1%
+ Depreciation and write-downs630€18,442€13,035€12,517€12,087€4,025€9,223€19,586▲ 112%
Operating cash flow (approximation)€19,672€18,525€61,857-€665€42,906€98,211€29,300▼ 70.2%
Investment in fixed assets (approximation)--€2,109-€2,199€0-€16,503-€63,468-€52,147▲ 17.8%
Change in cash-€43,001€65,741-€30,652-€282,978€20,115-€47,303-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 14 filings with the National Bank
Financial year Type Filed Reference
30-06-2025 micro format 27-01-2026 2026-00015953
30-06-2024 micro format 13-02-2025 2025-00035056
30-06-2023 micro format 10-01-2024 2024-00001558
30-06-2022 micro format 24-01-2023 2023-00009405
30-06-2021 micro format 21-01-2022 2022-02100066
30-06-2020 micro format 07-01-2021 2021-00700148
30-06-2019 micro format 30-01-2020 2020-04100396
30-06-2018 micro format 21-01-2019 2019-02200255
30-06-2017 micro format 12-01-2018 2018-01200374
30-06-2016 abbreviated format 27-01-2017 2017-02200296

Show all 14 filings

Similar companies · same sector, comparable size

Of the 16,577 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,106. 6,804 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 1 of 5 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

On 18 March 2011, INAVIUS was incorporated.1 Total assets went from €480,095 in 2019 to €300,336 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2019 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-01-2027
2026
27-01
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
13-02
NBB filing Annual accounts filed
financial year 2024 · micro format · 13 days late
12-02
Gazette deed Capital & shares · Purpose · Amendment of the articles
Declaration · Purpose change · Shareholding6 facts ▸
  • General meeting, 31-01-2025
  • Other provision, “agenda buitengewone algemene vergadering, Verklaring in toepassing van artikel 2:8 §4 Wetboek van vennootschappen en verenigingen” (deed in Dutch)
  • Declaration, “deontologisch toezicht artsen, ontwerp van onderhavige akte,houdende onder meer wijziging van het voorwerp,niet voorafgaandelijk ter controle voorgelegd aan bev…” (deed in Dutch)
  • Declaration, “alle verdere informatie-verplichtingen en verdere verantwoordelijkheid dienaangaande, ontslag notaris van informatieverplichtingen” (deed in Dutch)
  • Purpose change
  • Shareholding, “bestuursorgaan, artikel 2:8 § 4,2:12 en 2:14,4° Wetboek van vennootschappen en verenigingen” (deed in Dutch)
2024
30-06
Financial Highest result from 2019 to 2025net €88,988 ▲129%
Operating result €127,886, net result €88,988, both a record.
30-06
Financial Equity above €150,000equity €187,162 ▲37.1%
2 profitable years in a row build equity to €187,162.
10-01
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
30-06
Financial Back to profitnet €38,881
Net result €38,881 after one loss-making year.
30-06
Financial Liquidity more than doubledcurrent ratio 2.93
Current ratio from 1.24 to 2.93; short-term debt falls from €381,915 to €60,740.
30-06
Financial Equity above €100,000equity €136,522 ▲39.8%
Equity rises from €97,641 to €136,522.
24-01
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
30-06
Financial Weakest financial yearnet -€12,752
Net result drops to -€12,752, the lowest in the series; recovery starts the following year.
21-01
NBB filing Annual accounts filed
financial year 2021 · micro format
Show earlier events
2021
07-01
NBB filing Annual accounts filed
financial year 2020 · micro format
2020
30-01
NBB filing Annual accounts filed
financial year 2019 · micro format
2019
21-01
NBB filing Annual accounts filed
financial year 2018 · micro format
2018
12-01
NBB filing Annual accounts filed
financial year 2017 · micro format
2017
27-01
NBB filing Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 14 annual accounts filed, the latest 10 are here; all 14 are under Financials.
1 of 5 deeds read
About the unread acts

Of the 5 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded18-03-2011
Financial year end30-06
Activities, NACEBEL 2025
86220Specialist medical practice
70200Business and other management consultancy
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0834644814
Registered 27-03-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 16 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Tervuren · 2 establishment units since 2011
registered office establishment All 2 establishment units on the map
Ground area
1,205 m²
Building footprint
131 m²
Building volume
873 m³
2 parcels, Brussels, Flanders · tallest building 9.3 m. Linked by address, not a title deed.
3 companies at this address See who is registered here
2 establishment units
DR. BOSTEELS ARNAUD, ANESTHESIST
Kruidtuinlaan 32, 1000 BrusselSpecialist medical practice
since 2011unit no. 2.197.571.622
Eikestraat 111, 3080 Tervuren
Specialist medical practice
since 2014unit no. 2.302.916.392
2 parcels
Flanders 1 (50%) Brussels 1 (50%)
Cadastral parcel Region Area Buildings Height / floors
24302H0016/00R003 Flanders 1,046 m² 1 · 131 m² 9.3 m · 2
21802B0032/00R000 Brussels 159 m² - -
How the parcels are linked
Good to know
Both parcels match the address exactly.